Comparison Overview
Wanbang Biopharmaceuticals Co. Ltd
Wanbang Biopharmaceuticals Co. Ltd
经济开发区杨山路, 徐州市, 江苏省, 221004, CN
Last Update: 10/12/2025
The Brief Introduction of Wanbang Biopharmaceuticals Wanbang Biopharmaceuticals (brief in “Wanbang Biopharma”) is the core member of Shanghai Fosun Pharmaceutical (Group) Co., Ltd (brief in “Fosun Pharma”, stock code: 600196-SH, 02196-HK). Wanbang Biopharma was establis...
AUROBINDO PHARMA LTD
Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City, Raidurg Panmaktha, Ranga Reddy District,, Hyderabad, 500032, IN
Last Update: 03/04/2026
Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, brand...
Compliance Ranges Comparison
Wanbang Biopharmaceuticals Co. Ltd
AUROBINDO PHARMA LTD
Benchmark & Cyber Underwriting Signals
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for Wanbang Biopharmaceuticals Co. Ltd in 2026.
Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)
No incidents recorded for AUROBINDO PHARMA LTD in 2026.
Incident History - Wanbang Biopharmaceuticals Co. Ltd (X = Date, Y = Severity)
Wanbang Biopharmaceuticals Co. Ltd cyber incidents detection timeline including parent company and subsidiaries.
Incident History - AUROBINDO PHARMA LTD (X = Date, Y = Severity)
AUROBINDO PHARMA LTD cyber incidents detection timeline including parent company and subsidiaries.
Notable Incidents
Wanbang Biopharmaceuticals Co. Ltd
AUROBINDO PHARMA LTD
FAQ
Latest Global CVEs
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an inadequate encryption strength vulnerability which could allow an attacker to steal admin credentials via weak hash or a pass-the-hash attack.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could allow for asset discovery by unauthenticated users.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an unintended proxy or intermediary vulnerability which could allow an attacker to use an active proxy, which would bypass OT segmentation.
Pronetiqs IntraVUE Versions 3.2.1a14 and prior have a plaintext storage of a password vulnerability that could expose cleartext credentials through the API.
Pronetiqs IntraVUE versions 3.2.1a14 and prior have an exposure of sensitive system information to an unauthorized control sphere vulnerability which could expose the underlying host/share filesystem.